Article
Safety evaluation of standardized allergen extract of Japanese cedar pollen for sublingual immunotherapy.
Regulatory toxicology and pharmacology : RTP - 1 Apr 2015
Mitobe Yuko, Yokomoto Yasuki, Ohashi-Doi Katsuyo
Abstract excerpt
Japanese cedar (JC) pollinosis is caused by Japanese cedar pollen (JCP) and most common seasonal allergic disease in Japan. Subcutaneous immunotherapy (SCIT) with allergen extract of JCP (JCP-allergen extract) is well established for JC pollinosis treatment with improvement of symptoms. However, major drawbacks for SCIT are repeated painful injections, frequent hospital visits and anaphylactic risk. Currently,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
